COPENHAGEN (Reuters) - Danish pharmaceuticals company Novo Nordisk has asked its IT subsidiary NNIT to investigate the possibility of a separate listing of the business on the Copenhagen stock exchange, Nasdaq OMX Copenhagen, NNIT said on Wednesday.